Results 61 to 70 of about 222,830 (234)

Predictive value of estimated plasma volume for postoperative hypotension in percutaneous intramyocardial septal radiofrequency ablation treating for hypertrophic obstructive cardiomyopathy

open access: yesBMC Cardiovascular Disorders
Background Estimated plasma volume status (ePVS) estimated by the Duarte formula is associated with clinical outcomes in patients with heart failure.
Bo Shan   +8 more
doaj   +1 more source

Advances in hypertrophic cardiomyopathy: What the cardiologist needs to know

open access: yesRevista Portuguesa de Cardiologia, 2022
Hypertrophic cardiomyopathy (HCM) is known as the most common genetic heart disease, characterized by otherwise unexplained left ventricular (LV) hypertrophy.
Alexandra Toste
doaj  

Hypertrophic Cardiomyopathy: A Review

open access: yesClinical Medicine Insights: Cardiology, 2014
Hypertrophic cardiomyopathy (HCM) is a global disease with cases reported in all continents, affecting people of both genders and of various racial and ethnic origins. Widely accepted as a monogenic disease caused by a mutation in 1 of 13 or more sarcomeric genes, HCM can present catastrophically with sudden cardiac death (SCD) or ventricular ...
Brian A. Houston, Gerin R. Stevens
openaire   +5 more sources

Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations

open access: yesPflügers Archiv: European Journal of Physiology, 2019
Several lines of evidence suggest that the primary effect of hypertrophic cardiomyopathy mutations in human β-cardiac myosin is hypercontractility of the heart, which leads to subsequent hypertrophy, fibrosis, and myofilament disarray.
J. Spudich
semanticscholar   +1 more source

A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice

open access: yesScience, 2016
Powering down yields a healthier heart In hypertrophic cardiomyopathy (HCM), the heart muscle enlarges and becomes progressively less efficient at pumping blood. HCM can be caused by mutations in components of the sarcomere (the heart's contractile unit),
Eric M. Green   +18 more
semanticscholar   +1 more source

Management of Hypertrophic Cardiomyopathy

open access: yesAnnals of Global Health, 2014
Hypertrophic cardiomyopathy (HCM) is clinically defined as unexplained myocardial hypertrophy, and it is an autosomal dominant disease of the cardiac sarcomere. It is present in 1 in 500 in the general adult population, making it the most common genetic cardiovascular disease. The pathophysiology of HCM is complex, leading to significant variability in
Alan D. Enriquez, Martin E. Goldman
openaire   +4 more sources

Hypertrophic Cardiomyopathy: An Overview of Genetics and Management

open access: yesBiomolecules, 2019
Hypertrophic cardiomyopathy (HCM) is a genetically heterogeneous cardiac muscle disorder with a diverse natural history, characterized by unexplained left ventricular hypertrophy (LVH), with histopathological hallmarks including myocyte enlargement ...
P. Teekakirikul   +3 more
semanticscholar   +1 more source

Segmentation of the Myocardium on Late-Gadolinium Enhanced MRI based on 2.5 D Residual Squeeze and Excitation Deep Learning Model [PDF]

open access: yesarXiv, 2020
Cardiac left ventricular (LV) segmentation from short-axis MRI acquired 10 minutes after the injection of a contrast agent (LGE-MRI) is a necessary step in the processing allowing the identification and diagnosis of cardiac diseases such as myocardial infarction.
arxiv  

HeartBEiT: Vision Transformer for Electrocardiogram Data Improves Diagnostic Performance at Low Sample Sizes [PDF]

open access: yesarXiv, 2022
The electrocardiogram (ECG) is a ubiquitous diagnostic modality. Convolutional neural networks (CNNs) applied towards ECG analysis require large sample sizes, and transfer learning approaches result in suboptimal performance when pre-training is done on natural images.
arxiv  

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

open access: yesEuropean Heart Journal, 2014
2D : two-dimensional 99mTc-DPD : 99mTechnetium-3,3-diphosphono- 1,2-propanodi-carboxylic acid ACE : angiotensin-converting enzyme AF : atrial fibrillation AL : amyloid light chain AR : aortic regurgitation ARB : angiotensin receptor blocker ATTR ...
Perry M. Elliott   +19 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy